A Phase 1/2 Study of SB1518 for the Treatment of Advanced Myeloid Malignancies

Clinical trial NCT00719836 · COMPLETED

Trial details

NCT number: NCT00719836
Sponsor: S*BIO
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Myelogenous Leukemia Chronic Myelogenous Leukemia Chronic Myelomonocytic Leukemia Myelodysplastic Syndromes Myelofibrosis

Start date: 2008-08-01
Primary completion: 2012-01-01
Enrollment: 76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.